Chinese General Practice ›› 2021, Vol. 24 ›› Issue (26): 3369-3376.DOI: 10.12114/j.issn.1007-9572.2021.01.102
Special Issue: 共病最新文章合集
• Monographic Research • Previous Articles Next Articles
Published:
2021-09-15
Online:
2021-09-15
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.102
[1]MATHERS C D,LONCAR D. Projections of global mortality and burden of disease from 2002 to 2030[J]. PLoS Med,2006,3(11):e442. DOI:10.1371/journal.pmed.0030442. [2]VETRANO D L,CALDERóN-LARRA?AGA A,MARENGONI A,et al. An international perspective on chronic multimorbidity:approaching the elephant in the room[J]. J Gerontol A Biol Sci Med Sci,2018,73(10):1350-1356. DOI:10.1093/ andom/glx178. [3]DUGRAVOT A,FAYOSSE A,DUMURGIER J,et al. Social inequalities in multimorbidity,frailty,disability,and transitions to mortality:a 24-year follow-up of the Whitehall II cohort study[J]. Lancet Public Health,2020,5(1):e42-50. DOI:10.1016/S2468-2667(19)30226-9. [4]FU J M,LIU Y P,ZHANG L,et al. Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension[J]. J Am Heart Assoc,2020,9(19):e016804. DOI:10.1161/JAHA.120.016804. [5]LIANOV L,JOHNSON M. Physician competencies for prescribing lifestyle medicine[J]. JAMA,2010,304(2):202-203. DOI:10.1001/jama.2010.903. [6]MOKDAD A H,MARKS J S,STROUP D F,et al. Actual causes of death in the United States,2000[J]. JAMA,2004,291(10):1238-1245. DOI:10.1001/jama.291.10.1238. [7]BARNES P J.Mechanisms of development of multimorbidity in the elderly[J]. Eur Respir J,2015,45(3):790-806. DOI:10.1183/09031936.00229714. [8]FRIEDMAN E M,MROCZEK D K,CHRIST S L. Multimorbidity, inflammation,and disability:a longitudinal mediational analysis[J]. Ther Adv Chronic Dis,2019,10:2040622318806848. DOI:10.1177/2040622318806848. [9]JONES S A,JENKINS B J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer[J]. Nat Rev Immunol,2018,18(12):773-789. DOI:10.1038/s41577-018-0066-7. [10]STURMBERG J P,BENNETT J M,MARTIN C M,et al. ‘Multimorbidity’ as the manifestation of network disturbances[J]. J Eval Clin Pract,2017,23(1):199-208. DOI:10.1111/jep.12587. [11]DHALWANI N N,O'DONOVAN G,ZACCARDI F,et al. Long terms trends of multimorbidity and association with physical activity in older English population[J]. Int J Behav Nutr Phys Act,2016,13:8. DOI:10.1186/s12966-016-0330-9. [12]VANCAMPFORT D,KOYANAGI A,WARD P B,et al. Chronic physical conditions,multimorbidity and physical activity across 46 low- and middle-income countries[J]. Int J Behav Nutr Phys Act,2017,14(1):6. DOI:10.1186/s12966-017-0463-5. [13]HOPPS E,CANINO B,CAIMI G. Effects of exercise on inflammation markers in type 2 diabetic subjects[J]. Acta Diabetol,2011,48(3):183-189. DOI:10.1007/s00592-011-0278-9. [14]PEDERSEN B K. The anti-inflammatory effect of exercise:its role in diabetes and cardiovascular disease control[J]. Essays Biochem,2006,42:105-117. DOI:10.1042/bse0420105. [15]HOJMAN P,GEHL J,CHRISTENSEN J F,et al. Molecular mechanisms linking exercise to cancer prevention and treatment[J]. Cell Metab,2018,27(1):10-21. DOI:10.1016/j.cmet.2017.09.015. [16]HAWLEY J A,HARGREAVES M,JOYNER M J,et al. Integrative biology of exercise[J]. Cell,2014,159(4):738-749. DOI:10.1016/j.cell.2014.10.029. [17]FERREIRA R C,FREITAG D F,CUTLER A J,et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases[J]. PloS Genet,2013,9(4):e1003444. DOI:10.1371/journal.pgen.1003444. [18]LI Y,FENG J,SONG S,et al. Gp130 controls cardiomyocyte proliferation and heart regeneration[J]. Circulation,2020,142(10):967-982. DOI:10.1161/CIRCULATIONAHA.119.044484. [19]GLEESON M,BISHOP N C,STENSEL D J,et al. The anti-inflammatory effects of exercise:mechanisms and implications for the prevention and treatment of disease[J]. Nat Rev Immunol,2011,11(9):607-615. DOI:10.1038/nri3041. [20]WALSH N P,GLEESON M,SHEPHARD R J,et al. Position statement.Part one:Immune function and exercise[J]. Exerc Immunol Rev,2011,17:6-63. [21]WEDELL-NEERGAARD A S,LANG LEHRSKOV L,CHRISTENSEN R H,et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling:a randomized controlled trial[J]. Cell Metab,2019,29(4):844-855.e3. DOI:10.1016/j.cmet.2018.12.007. [22]FULLER K N Z,SUMMERS C M,VALENTINE R J. Effect of a single bout of aerobic exercise on high-fat meal-induced inflammation[J]. Metabolism,2017,71:144-152. DOI:10.1016/j.metabol.2017.03.001. [23]WEINHOLD M,SHIMABUKURO-VORNHAGEN A,FRANKE A,et al. Physical exercise modulates the homeostasis of human regulatory T cells[J]. J Allergy Clin Immunol,2016,137(5):1607-1610.e8. DOI:10.1016/j.jaci.2015.10.035. [24]DESDíN-MICó G,SOTO-HEREDERO G,ARANDA J F,et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence[J]. Science,2020,368(6497):1371-1376. DOI:10.1126/science.aax0860. [25]HOOD D A,MEMME J M,OLIVEIRA A N,et al. Maintenance of skeletal muscle mitochondria in health,exercise,and aging[J]. Annu Rev Physiol,2019,81:19-41. DOI:10.1146/annurev-physiol-020518-114310. [26]ZHENG J J,PENA CALDERIN E,HILL B G,et al. Exercise promotes resolution of acute inflammation by catecholamine-mediated stimulation of andomize D1 biosynthesis[J]. J Immunol,2019,203(11):3013-3022. DOI:10.4049/jimmunol.1900144. [27]KRüGER K,AGNISCHOCK S,LECHTERMANN A,et al. Intensive resistance exercise induces lymphocyte apoptosis via cortisol and glucocorticoid receptor-dependent pathways[J]. J Appl Physiol(1985),2011,110(5):1226-1232. DOI:10.1152/japplphysiol.01295.2010. [28]DUGGAL N A,POLLOCK R D,LAZARUS N R,et al. Major features of immunesenescence,including reduced thymic output,are ameliorated by high levels of physical activity in adulthood[J]. Aging Cell,2018,17(2):e12750. DOI:10.1111/acel.12750. [29]DUGGAL N A,NIEMIRO G,HARRIDGE S D R,et al. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?[J]. Nat Rev Immunol,2019,19(9):563-572. DOI:10.1038/s41577-019-0177-9. [30]ROSSMAN M J,KAPLON R E,HILL S D,et al. Endothelial cell senescence with aging in healthy humans:prevention by habitual exercise and relation to vascular endothelial function[J]. Am J Physiol Heart Circ Physiol,2017,313(5):H890-895. DOI:10.1152/ajpheart.00416.2017. [31]FIUZA-LUCES C,SANTOS-LOZANO A,JOYNER M,et al. Exercise benefits in cardiovascular disease:beyond attenuation of traditional risk factors[J]. Nat Rev Cardiol,2018,15(12):731-743. DOI:10.1038/s41569-018-0065-1. [32]HOU Z X,QIN X H,HU Y Y,et al. Longterm exercise-derived exosomal miR-342-5p:a novel exerkine for cardioprotection[J]. Circ Res,2019,124(9):1386-1400. DOI:10.1161/CIRCRESAHA.118.314635. [33]ZHANG Y,WAN J Y,LIU S Q,et al. Exercise induced improvements in insulin sensitivity are concurrent with reduced NFE2/miR-432-5p and increased FAM3A[J]. Life Sci,2018,207:23-29. DOI:10.1016/j.lfs.2018.05. 040. [34]DENHAM J,MARQUES F Z,O'BRIEN B J,et al. Exercise:putting action into our epigenome[J]. Sports Med,2014,44(2):189-209. DOI:10.1007/s40279-013-0114-1. [35]BROWN W M. Exercise-associated DNA methylation change in skeletal muscle and the importance of imprinted genes:a bioinformatics meta-analysis[J]. Br J Sports Med,2015,49(24):1567-1578. DOI:10.1136/bjsports-2014-094073. [36]JOSEPH J S,AYELESO A O,MUKWEVHO E. Exercise increases hyper-acetylation of histones on the Cis-element of NRF-1 binding to the Mef2a promoter:implications on type 2 diabetes[J]. Biochem Biophys Res Commun,2017,486(1):83-87. DOI:10.1016/j.bbrc.2017.03.002. [37]LIGIBEL J A,DILLON D,GIOBBIE-HURDER A,et al. Impact of a pre-operative exercise intervention on breast cancer proliferation and gene expression:results from the pre-operative health and body(PreHAB) study[J]. Clin Cancer Res,2019,25(17):5398-5406. DOI:10.1158/1078-0432.CCR-18-3143. [38]DEKKER J,BUURMAN B M,VAN DER LEEDEN M. Exercise in people with comorbidity or multimorbidity[J]. Health Psychol,2019,38(9):822-830. DOI:10.1037/hea0000750. [39]RAUTIAINEN S,MANSON J E,LICHTENSTEIN A H,et al. Dietary supplements and disease prevention-a global overview[J]. Nat Rev Endocrinol,2016,12(7):407-420. DOI:10.1038/nrendo.2016.54. [40]GBD DIET COLLABORATORS. Health effects of dietary risks in 195 countries,1990—2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet,2019,393(10184):1958-1972. DOI:10.1016/S0140-6736(19)30041-8. [41]ESTRUCH R,ROS E,SALAS-SALVADó J,et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts[J]. N Engl J Med,2018,378(25):e34. DOI:10.1056/nejmoa1800389. [42]AZADBAKHT L,FARD N R,KARIMI M,et al. Effects of the Dietary Approaches to Stop Hypertension(DASH) eating plan on cardiovascular risks among type 2 diabetic patients:a randomized crossover clinical trial[J]. Diabetes Care,2011,34(1):55-57. DOI:10.2337/dc10-0676. [43]TANGESTANI H,SALARI-MOGHADDAM A,GHALANDARI H,et al. Adherence to the Dietary Approaches to Stop Hypertension(DASH) dietary pattern reduces the risk of colorectal cancer:a systematic review and meta-analysis[J]. Clin Nutr,2020,39(10):2975-2981. DOI:10.1016/j.clnu.2020.02.002. [44]CHRIST A,GüNTHER P,LAUTERBACH M A R,et al. Western diet triggers NLRP3-dependent innate immune reprogramming[J]. Cell,2018,172(1/2):162-175.e14. DOI:10.1016/j.cell.2017.12.013. [45]SAMIR P,MALIREDDI R K S,KANNEGANTI T D. Food for training-western diet and inflammatory memory[J]. Cell Metab,2018,27(3):481-482. DOI:10.1016/j.cmet.2018.02.012. [46]HAYASHI T,FUJITA K,NOJIMA S,et al. High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling[J]. Clin Cancer Res,2018,24(17):4309-4318. DOI:10.1158/1078-0432.CCR-18-0106. [47]ROAGER H M,VOGT J K,KRISTENSEN M,et al. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome:a andomized cross-over trial[J]. Gut,2019,68(1):83-93. DOI:10.1136/gutjnl-2017-314786. [48]MOZAFFARIAN D. Dietary and policy priorities for cardiovascular disease,diabetes,and obesity:a comprehensive review[J]. Circulation,2016,133(2):187-225. DOI:10.1161/CIRCULATIONAHA.115.018585. [49]REDMAN L M,SMITH S R,BURTON J H,et al. Metabolic slowing and reduced oxidative damage with sustained caloric restriction support the rate of living and oxidative damage theories of aging[J]. Cell Metab,2018,27(4):805-815.e4. DOI:10.1016/j.cmet.2018.02.019. [50]FONTANA L,PARTRIDGE L,LONGO V D. Extending healthy life span——from yeast to humans[J]. Science,2010,328(5976):321-326. DOI:10.1126/science.1172539. [51]PICARD M,WALLACE D C,BURELLE Y.The rise of mitochondria in medicine[J]. Mitochondrion,2016,30:105-116. DOI:10.1016/j.mito.2016.07.003. [52]LEE C,ZENG J,DREW B G,et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance[J]. Cell Metab,2015,21(3):443-454. DOI:10.1016/j.cmet. 2015.02.009. [53]TUMURKHUU G,SHIMADA K,DAGVADORJ J,et al. Ogg1-dependent DNA repair regulates NLRP3 inflammasome and prevents atherosclerosis[J]. Circ Res,2016,119(6):e76-90. DOI:10.1161/CIRCRESAHA.116.308362. [54]ARON-WISNEWSKY J,CLéMENT K.The gut microbiome,diet,and links to cardiometabolic and chronic disorders[J]. Nat Rev Nephrol,2016,12(3):169-181. DOI:10.1038/nrneph.2015.191. [55]GENTILE C L,WEIR T L. The gut microbiota at the intersection of diet and human health[J]. Science,2018,362(6416):776-780. DOI:10.1126/science.aau5812. [56]XIE Y D,ZHAO Y F,SHI L,et al. Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer[J]. J Clin Invest,2020,130(4):2111-2128. DOI:10.1172/JCI133264. [57]CATRY E,BINDELS L B,TAILLEUX A,et al. Targeting the gut microbiota with inulin-type fructans:preclinical demonstration of a novel approach in the management of endothelial dysfunction[J]. Gut,2018,67(2):271-283. DOI:10.1136/gutjnl-2016-313316. [58]AROKIASAMY P,UTTAMACHARYA U,JAIN K,et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries:what does the study on global ageing and adult health (SAGE) reveal?[J]. BMC Med,2015,13:178. DOI:10.1186/s12916-015-0402-8. [59]YAMANASHI H,NOBUSUE K,NONAKA F,et al. The role of mental disease on the association between multimorbidity and medical expenditure[J]. Fam Pract,2020,37(4):453-458. DOI:10.1093/fampra/cmaa015. [60]SCHULZE T,MAERCKER A,HORN A B. Mental health and multimorbidity:psychosocial adjustment as an important process for quality of life[J]. Gerontology,2014,60(3):249-254. DOI:10.1159/000358559. [61]VOS R,AARTS S,VAN MULLIGEN E,et al. Finding potentially new multimorbidity patterns of psychiatric and somatic diseases:exploring the use of literature-based discovery in primary care research[J]. J Am Med Inform Assoc,2014,21(1):139-145. DOI:10.1136/amiajnl-2012-001448. [62]THOMA M V,GIANFERANTE D,HANLIN L K,et al. Stronger hypothalamus-pituitary-adrenal axis habituation predicts lesser sensitization of inflammatory response to repeated acute stress exposures in healthy young adults[J]. Brain Behav Immun,2017,61:228-235. DOI:10.1016/j.bbi.2016.11.030. [48]VIGNES S,ARRAULT M,DUPUY A. Factors associated with increased breast cancer-related lymphedema volume[J]. Acta Oncol,2007,46(8):1138-1142. DOI:10.1080/02841860701403020. [49]LACOMBE J,MANGé A,BOUGNOUX A C,et al. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women[J]. Cancer Epidemiol Biomarkers Prev,2014,23(9):1834-1842. DOI:10.1158/1055-9965.EPI-14-0267. [50]陈怡安,贾红燕,张萌萌,等. 35岁以下三阴性乳腺癌临床病理特征及预后分析[J]. 海南医学,2019,30(13):1657-1663. DOI:10.3969/j.issn.1003-6350.2019.13.006. CHEN Y A,JIA H Y,ZHANG M M,et al. Clinicopathological features and prognosis of very young women(<35 years)with triple-negative breast cancer[J]. Hainan Medical Journal,2019,30(13):1657-1663. DOI:10.3969/j.issn.1003-6350.2019.13.006. [51]MICHELOTTI A,INVERNIZZI M,LOPEZ G,et al. Tackling the diversity of breast cancer related lymphedema:perspectives on diagnosis,risk assessment,and clinical management[J]. Breast,2019,44:15-23. DOI:10.1016/j.breast.2018.12.009. [52]WEYCKER D,CHANDLER D,BARRON R,et al. Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice[J]. J Oncol Pharm Pract,2017,23(1):33-42. DOI:10.1177/1078155215614997. [53]范威,吴新红. 乳腺癌新辅助化疗后手术时机的选择[J]. 临床外科杂志,2019,27(3):183-186. DOI:10.3969/j.issn.1005-6483.2019.03.002. https://d.wanfangdata.com.cn/periodical/lcwkzz201903002. [54]蔡耿喜,蔡子杰,陈前军,等. 乳腺癌新辅助化疗的现状与进展——南方乳腺癌论坛主要议题与共识[J]. 中国普通外科杂志,2019,28(11):1309-1321. DOI:10.7659/j.issn.1005-6947.2019.11.001. [63]MASON A E,SCHLEICHER S,COCCIA M,et al. Chronic stress and impulsive risk-taking predict increases in visceral fat over 18 months[J]. Obesity(Silver Spring),2018,26(5):869-876. DOI:10.1002/oby.22150. [64]NUSSLOCK R,MILLER G E. Early-life adversity and physical and emotional health across the lifespan:a neuroimmune network hypothesis[J]. Biol Psychiatry,2016,80(1):23-32. DOI:10.1016/j.biopsych.2015. 05.017. [65]GAULIN M,SIMARD M,CANDAS B,et al. Combined impacts of multimorbidity and mental disorders on frequent emergency department visits:a retrospective cohort study in Quebec,Canada[J]. CMAJ,2019,191(26):E724-732. DOI:10.1503/cmaj.181712. [66]COVENTRY P,LOVELL K,DICKENS C,et al. Integrated primary care for patients with mental and physical multimorbidity:cluster andomized controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease[J]. BMJ,2015,350:h638. DOI:10.1136/bmj.h638. [67]BODENHEIMER T,LORIG K,HOLMAN H,et al. Patient self-management of chronic disease in primary care[J]. JAMA,2002,288(19):2469-2475. DOI:10.1001/jama.288.19.2469. [68]ABOUMATAR H,NAQIBUDDIN M,CHUNG S,et al. Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease:a randomized clinical trial[J]. JAMA,2019,322(14):1371-1380. DOI:10.1001/jama.2019.11982. [69]PETERS M,POTTER C M,KELLY L,et al. Self-efficacy and health-related quality of life:a cross-sectional study of primary care patients with multi-morbidity[J]. Health Qual Life Outcomes,2019,17(1):37. DOI:10.1186/s12955-019-1103-3. [70]YOUNG L A,BUSE J B,WEAVER M A,et al. Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings:a randomized trial[J]. JAMA Intern Med,2017,177(7):920-929. DOI:10.1001/jamainternmed.2017.1233. [71]LUM E,JIMENEZ G,HUANG Z L,et al. Decision support and alerts of apps for self-management of blood glucose for type 2 diabetes[J]. JAMA,2019,321(15):1530-1532. DOI:10.1001/jama.2019.1644. [72]HELGESON V S,JAKUBIAK B,VAN VLEET M,et al. Communal coping and adjustment to chronic illness:theory update and evidence[J]. Pers Soc Psychol Rev,2018,22(2):170-195. DOI:10.1177/1088868317735767. [73]OCHOA-AVILéS A,VERSTRAETEN R,HUYBREGTS L,et al. A school-based intervention improved dietary intake outcomes and reduced waist circumference in adolescents:a cluster randomized controlled trial[J]. Nutr J,2017,16(1):79. DOI:10.1186/s12937-017-0299-5. [74]DOWNER S,BERKOWITZ S A,HARLAN T S,et al. Food is medicine:actions to integrate food and nutrition into healthcare[J]. BMJ,2020,369:m2482. DOI:10.1136/bmj.m2482. [75]ABRAHA I,CRUZ-JENTOFT A,SOIZA R L,et al. Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions:the SENATOR-ONTOP systematic review protocol[J]. BMJ Open,2015,5(1):e007488. DOI:10.1136/bmjopen-2014-007488. |
[1] | HE Li, ZHANG Yifan, SHEN Xuechun, SUN Yan, ZHAO Yang. Prevalence Trends of Multimorbidity among Residents in Mainland China: a Meta-analysis [J]. Chinese General Practice, 2023, 26(29): 3599-3607. |
[2] | PAN Ye, LIU Zhihui, HU Qianqian, WANG Liuyi. Patterns of Coexistence of Multiple Chronic Conditions among Chinese Elderly [J]. Chinese General Practice, 2023, 26(29): 3608-3615. |
[3] | ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621. |
[4] | LIN Yang, WANG Fang, WANG Han, WU Rong, WANG Yao, XU Ziyao, WANG Xu, WANG Yanding. Prevalence of Frailty in Elderly Patients with Comorbidity: a Meta-analysis [J]. Chinese General Practice, 2023, 26(25): 3185-3193. |
[5] | ZHENG Xiao, TIAN Feng, CHEN Yiming, XUE Benli, SHI Lei, ZHANG Chichen. Research Hotspots and Evolutionary Trends on Multimorbidity in China from 2002 to 2022 [J]. Chinese General Practice, 2023, 26(21): 2567-2573. |
[6] | FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580. |
[7] | China Gerontological Nursing Alliance, Xiang Ya Nursing School Central South University (Xiangya Oceanwide Health Management Research Institute of Central South University), Xiangya Hospital Central South University (National Clinical Research Center for Geriatric Disorders), Beijing Hospital (National Center for Gerontology, National Clinical Research Center for Geriatric Disorders), LI Mengqi, WU Lina, NING Hongting, FENG Hui. Clinical Practice Guideline for Non-pharmacological Interventions for Malnourished Elderly [J]. Chinese General Practice, 2023, 26(17): 2055-2069. |
[8] | China Gerontological Nursing Alliance, Xiang Ya Nursing School (Xiangya Oceanwide Health Management Research Institute of Central South University), Xiangya Hospital Central South University (National Clinical Research Center for Geriatric Disorders), Beijing Hospital (National Center for Gerontology, National Clinical Research Center for Geriatric Disorders), ZENG Xianmei, HU Mingyue, FENG Hui. Clinical Practice Guideline on Non-pharmacological Interventions for Older Adults with Cognitive Dysfunction: Physical Activity [J]. Chinese General Practice, 2023, 26(16): 1927-1937,1971. |
[9] | ZHU Yuqin, JIN Hua, YU Dehua. Choice of a Healthcare Institution and Associated Factors in Patients with Multimorbidity during the Implementation of Hierarchical Medical System [J]. Chinese General Practice, 2023, 26(13): 1598-1604. |
[10] | BAI Dingxi, GAO Jing, YANG Zhi, WU Chenxi. Development of a Treatment Burden Scale for Elderly Patients with Coexisting Chronic Diseases [J]. Chinese General Practice, 2023, 26(13): 1613-1620. |
[11] | SONG Yinhua, LIU Yushuang, YANG Qing, WANG Shibin, HU Qing, ZHENG Chunchan, ZHANG Ping. Correlation of Subjective Cognitive Decline with Multimorbidity among Elderly People [J]. Chinese General Practice, 2023, 26(10): 1241-1249. |
[12] | CHEN Xiaomin, ZHANG Lina, LI Youjia. Characteristic of Polypharmacy in Older Adults with Type 2 Diabetes [J]. Chinese General Practice, 2023, 26(10): 1271-1277. |
[13] | QI Yuantao, LIU Yan, DU Jin, LIU Yongwen, MA Guifeng. The Influencing Factors of Chronic Disease Comorbidities of Elderly in China Based on Health Ecology Model [J]. Chinese General Practice, 2023, 26(01): 50-57. |
[14] | YAN Xuedan, CHEN Shanping, ZHOU Lihua, WANG Lingxiao, YANG Yongxue, REN Yan. Risk Factors of Cognitive Frailty in Hospitalized Older Patients with Comorbidities and Its Implication for Patient Outcomes [J]. Chinese General Practice, 2022, 25(31): 3877-3883. |
[15] | ZHANG Zhenxiang, HE Fupei, ZHANG Chunhui, LIN Beilei, PING Zhiguang, GUO Huijuan. Latent Class Analysis and Influencing Factors of Medication Adherence in Multiple Chronic Conditions Patients [J]. Chinese General Practice, 2022, 25(31): 3904-3913. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||